An international trial has found that GMRx2, a single pill combining three low-dose blood pressure drugs, reduced recurrent stroke risk by 39% in patients with intracerebral hemorrhage. The TRIDENT ...

Drugmakers continue to test weight-loss medicines against dummy pills and shots, even with a growing number of effective approved obesity drugs. This practice raises practical questions.

Treatment with GMRx2, a single pill combination of three low-dose blood pressure medicines, significantly reduced the risk of ...

Today, the Company presented results from a Phase 2b dose-ranging and proof of concept study of elismetrep, a novel TRPM8 channel blocker and the only agent known to be in late-stage development for ...

Every 67 seconds, someone in the United States develops Alzheimer’s disease. By April 2026, roughly 7 million Americans aged ...

A new method replicated the findings of a previous clinical trial of Tecfidera in people with relapsing-remitting MS, a study ...

This approval marks an important new chapter in Merck’s long-standing commitment to research and discovery for people living ...

As published in The Lancet and presented at AAN, NIMBLE trial met its primary and key secondary endpoints at week 24, demonstrating potential ...

Introduction Despite its serious impact, anorexia nervosa (AN) remains one of the least understood mental illnesses, with significant gaps in effective treatment options. No medications have been ...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that the journal Annals of Internal Medicine has published an article chronicling the full 12-month data set ...